
How Neuroplasticity Is Shaping the Next Generation of Psychiatric Medicines
Dr. Aaron Koenig, Chief Medical Officer at Delix Therapeutics, sheds light on a new class of medicines designed to promote neuroplasticity without the hallucinogenic effects associated with psychedelics. On this episode























